Studies on bacterial cell wall inhibitors. VI. Screening method for the specific inhibitors of peptidogylcan synthesis
S. Ōmura Studies on bacterial cell wall inhibitors. VI. Screening method for the specific inhibitors of peptidogylcan synthesis J. Antibiot. (Tokyo) 32 1979 978 984
Two new species of the genus Kitasatosporia, Kitasatosporia phosalacinea sp. nov. and Kitasatosporia griseola sp. nov
Y. Takahashi Two new species of the genus Kitasatosporia, Kitasatosporia phosalacinea sp. nov. and Kitasatosporia griseola sp. nov J. Genet. Appl. Microbiol. 30 1984 377 387
Avermectins, new family of potent anthelmintic agents: Isolation and chromatographic properties
T.W. Miller Avermectins, new family of potent anthelmintic agents: isolation and chromatographic properties Antimicrob. Agents Chemother. 15 1979 368 371
APOC's strategy of community-directed treatment with ivermectin (CTDI) and its potential for providing additional health services to the poorest populations
M. Homeida APOC's strategy of community-directed treatment with ivermectin (CTDI) and its potential for providing additional health services to the poorest populations Ann. Trop. Med. Parasitol. 96 2002 S93 104
Genome sequence of an industrial microorganism Streptomyces avermitilis: Deducing the ability of producing secondary metabolites
S. Ōmura Genome sequence of an industrial microorganism Streptomyces avermitilis: deducing the ability of producing secondary metabolites Proc. Natl. Acad. Sci. U. S. A. 98 2001 12215 12220
Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages
I. Namatame Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages Proc. Natl. Acad. Sci. U. S. A. 101 2004 737 742
Suppression of bone resorption by madindoline A, a novel non-peptide antagonist to gp130
M. Hayashi Suppression of bone resorption by madindoline A, a novel non-peptide antagonist to gp130 Proc. Natl. Acad. Sci. U. S. A. 99 2002 14728 14733